Cryomass Technologies Inc: operating income or loss
Operating income or loss for Cryomass Technologies Inc. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All Cryomass Technologies Inc financial histories
What this measure means
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
Exact concept: us-gaap:OperatingIncomeLoss. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2011-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2023-01-01 | 2023-12-31 | -10,782,097 | USD | 2024-06-14 | 10-K · 0001213900-24-052565 |
| 2022-01-01 | 2022-12-31 | -10,311,810 | USD | 2024-06-14 | 10-K · 0001213900-24-052565 |
| 2021-01-01 | 2021-12-31 | -7,991,827 | USD | 2023-03-24 | 10-K · 0001213900-23-022859 |
| 2020-01-01 | 2020-12-31 | -6,534,841 | USD | 2022-03-28 | 10-K · 0001213900-22-015544 |
| 2019-01-01 | 2019-12-31 | -3,332,930 | USD | 2021-03-30 | 10-K · 0001213900-21-018703 |
| 2018-01-01 | 2018-12-31 | -337,770 | USD | 2020-04-03 | 10-K · 0001213900-20-008478 |
| 2017-01-01 | 2017-12-31 | -52,071 | USD | 2019-05-24 | 10-K · 0001062993-19-002406 |
| 2016-01-01 | 2016-12-31 | -46,122 | USD | 2018-05-01 | 10-K · 0001062993-18-001857 |
| 2015-01-01 | 2015-12-31 | -22,245 | USD | 2018-01-05 | 10-K · 0001062993-18-000029 |
| 2014-01-01 | 2014-12-31 | -33,087 | USD | 2017-04-20 | 10-K · 0001062993-17-001988 |
| 2013-01-01 | 2013-12-31 | -60,760 | USD | 2015-03-30 | 10-K · 0001062993-15-001617 |
| 2012-01-01 | 2012-12-31 | -50,007 | USD | 2014-03-25 | 10-K · 0001062993-14-001576 |
| 2011-01-01 | 2011-12-31 | -46,507 | USD | 2013-03-06 | 10-K · 0001062993-13-001066 |
Related financial histories
- Cryomass Technologies Inc: total assets
- Cryomass Technologies Inc: total liabilities
- Cryomass Technologies Inc: stockholders equity
- Cryomass Technologies Inc: cash and cash equivalents
- Cryomass Technologies Inc: net income or loss
- Cryomass Technologies Inc: operating cash flow
- Cryomass Technologies Inc: capital expenditure payments
- Cryomass Technologies Inc: revenue
- Cryomass Technologies Inc: financing cash flow
- Cryomass Technologies Inc: investing cash flow
- Cryomass Technologies Inc: retained earnings or deficit
- Cryomass Technologies Inc: basic weighted-average shares
- Cryomass Technologies Inc: diluted weighted-average shares
- Cryomass Technologies Inc: basic earnings per share
- Cryomass Technologies Inc: diluted earnings per share
- Cryomass Technologies Inc: income tax expense or benefit
- Cryomass Technologies Inc: net property, plant and equipment
- Cryomass Technologies Inc: share-based compensation expense
- Cryomass Technologies Inc: current assets
- Cryomass Technologies Inc: interest expense
- Cryomass Technologies Inc: current liabilities
- Cryomass Technologies Inc: current accounts payable
- Cryomass Technologies Inc: goodwill carrying amount
- Cryomass Technologies Inc: net finite-lived intangible assets
- Cryomass Technologies Inc: net current accounts receivable
- Cryomass Technologies Inc: operating expenses
- Cryomass Technologies Inc: net inventory
- Cryomass Technologies Inc: gross profit
- Cryomass Technologies Inc: cost of revenue
- Cryomass Technologies Inc: research and development expense
- Cryomass Technologies Inc: common shares outstanding
- Cryomass Technologies Inc: cash including restricted cash
- Cryomass Technologies Inc: additional paid-in capital
- Cryomass Technologies Inc: accumulated other comprehensive income or loss
- Cryomass Technologies Inc: total equity including noncontrolling interests
- Cryomass Technologies Inc: gross property, plant and equipment
- Cryomass Technologies Inc: accumulated depreciation on property, plant and equipment
- Cryomass Technologies Inc: net intangible assets excluding goodwill
- Cryomass Technologies Inc: accrued current liabilities
- Cryomass Technologies Inc: net deferred tax assets
- Cryomass Technologies Inc: pre-tax income or loss from continuing operations
- Cryomass Technologies Inc: profit or loss including noncontrolling interests
- Cryomass Technologies Inc: comprehensive income or loss
- Cryomass Technologies Inc: general and administrative expense
- Cryomass Technologies Inc: depreciation expense
- Cryomass Technologies Inc: amortization of intangible assets
- Cryomass Technologies Inc: nonoperating income or expense
- Cryomass Technologies Inc: deferred income tax expense or benefit
- Cryomass Technologies Inc: interest paid, net
- Cryomass Technologies Inc: proceeds from issuing common stock
- Cryomass Technologies Inc: operating lease payments
- Cryomass Technologies Inc: change in accounts receivable
- Cryomass Technologies Inc: change in inventories
Inspect the source
- Entity
- Cryomass Technologies Inc / CIK 0001533030
- Captured
- 2026-09-21T17:20:33.773Z
- SEC response SHA-256
da590d354511a80c2e2a72838ddbef90552a18191b9c1a6cb553b1882a82de62
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001533030.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))